OR WAIT null SECS
August 01, 2014
With a number of branded biologics hanging at the patent cliff, the future looks promising for biosimilars.
To realise the full potential for biosimilars, stakeholders must build a better understanding of biosimilars and to take a comprehensive view of how these important medicines can fit into treatment pathways.
Representatives of contract service organizations that develop biologic-based drugs discussed technology trends such as high-throughput screening and single-use systems.
July 24, 2014
Sandoz is first to file for FDA approval of a biologic under the biosimilars pathway created in the Biologics Price Competition and Innovation Act of 2009.
July 10, 2014
New International Council on Biotechnology Associations advocates biotechnology growth.
July 02, 2014
Several groups, including pharmacies, call on FDA to preserve accepted International Nonproprietary Name conventions for biosimilars.
June 30, 2014
Biotage has launched a purification technology, Accelerated Chromatographic Isolation (ACI), which converts simple flash purification into a faster and more economical way to isolate pure compounds.
June 16, 2014
Novartis facility becomes the first US site licensed by the FDA to produce cell-culture influenza vaccines.
June 12, 2014
A new report from GlobalData states that biosimilars will overtake the market share after 2019.
May 15, 2014
What challenges do biopharmaceutical manufacturers face when deciding to move from a fed batch process to a continuous process?